Incyte (INCY) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Incyte (INCY)

INCY 105.97

0.0%

Nov 10 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: scaram(o)uche	9/24/2013 12:31:40 PM
	of 3202

110 ACR abstract is out..... twitter.com If you listen between the lines at Morgan Stanley, looks like 110 is up for licensing, whereas they might license or independently develop 986?? OTOH, they're looking to compare this trial...... clinicaltrials.gov with this one..... clinicaltrials.gov to determine how to proceed with pancreatic. Both trials are open label. Please correct me if I'm wrong at any point, doing this from memory. A reminder that I'm certain none of you need..... psoriasis 110 phase I to be presented here....... istanbul2013.eadv.org Call me jaded or beaten about head too many times, I've come to expect little from psoriasis trials.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next